In this issue:
Orelabrutinib in relapsed or refractory Waldenström's macroglobulinaemia
Hyper-CVAD & blinatumomab for newly diagnosed Philadelphia chromosome-negative B-cell ALL
Risk of second primary malignancies with lenalidomide
Ascending doses of mitapivat in sickle cell anaemia
Abnormal uterine bleeding after anticoagulants for acute venous thromboembolism
Avapritinib in previously treated advanced systemic mastocytosis
Patient- & physician-reported pain after TKI discontinuation for chronic myeloid leukaemia
Eltrombopag ± rabbit ATG–based immunosuppressive therapy in severe aplastic anaemia
Tacrolimus as a steroid-sparing treatment in autoimmune cytopenia
Ruxolitinib in relapsed or refractory classical Hodgkin lymphoma
Please login below to download this issue (PDF)